Pharma & Healthcare
Global Kidney Cancer or Renal Cancer Market Research Report 2026
- May 01, 26
- ID: 748042
- Pages: 117
- Figures: 115
- Views: 8
This report delivers a comprehensive overview of the global Kidney Cancer or Renal Cancer market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Kidney Cancer or Renal Cancer. The Kidney Cancer or Renal Cancer market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Kidney Cancer or Renal Cancer market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Kidney Cancer or Renal Cancer manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck & Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Pfizer
GSK
Segment by Type
Targeted Therapy
Chemotherapy
Immunotherapy
Segment by Application
Hospital
Pharmacy
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Kidney Cancer or Renal Cancer companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Kidney Cancer or Renal Cancer market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Kidney Cancer or Renal Cancer manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck & Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Pfizer
GSK
Segment by Type
Targeted Therapy
Chemotherapy
Immunotherapy
Segment by Application
Hospital
Pharmacy
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Kidney Cancer or Renal Cancer companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney Cancer or Renal Cancer Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.3 Market by Application
1.3.1 Global Kidney Cancer or Renal Cancer Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Kidney Cancer or Renal Cancer Market Perspective (2021–2032)
2.2 Global Kidney Cancer or Renal Cancer Growth Trends by Region
2.2.1 Global Kidney Cancer or Renal Cancer Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Kidney Cancer or Renal Cancer Historic Market Size by Region (2021–2026)
2.2.3 Kidney Cancer or Renal Cancer Forecasted Market Size by Region (2027–2032)
2.3 Kidney Cancer or Renal Cancer Market Dynamics
2.3.1 Kidney Cancer or Renal Cancer Industry Trends
2.3.2 Kidney Cancer or Renal Cancer Market Drivers
2.3.3 Kidney Cancer or Renal Cancer Market Challenges
2.3.4 Kidney Cancer or Renal Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kidney Cancer or Renal Cancer Players by Revenue
3.1.1 Global Top Kidney Cancer or Renal Cancer Players by Revenue (2021–2026)
3.1.2 Global Kidney Cancer or Renal Cancer Revenue Market Share by Players (2021–2026)
3.2 Global Top Kidney Cancer or Renal Cancer Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Kidney Cancer or Renal Cancer Revenue
3.4 Global Kidney Cancer or Renal Cancer Market Concentration Ratio
3.4.1 Global Kidney Cancer or Renal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer or Renal Cancer Revenue in 2025
3.5 Global Key Players of Kidney Cancer or Renal Cancer Head Offices and Areas Served
3.6 Global Key Players of Kidney Cancer or Renal Cancer, Products and Applications
3.7 Global Key Players of Kidney Cancer or Renal Cancer, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Kidney Cancer or Renal Cancer Breakdown Data by Type
4.1 Global Kidney Cancer or Renal Cancer Historic Market Size by Type (2021–2026)
4.2 Global Kidney Cancer or Renal Cancer Forecasted Market Size by Type (2027–2032)
5 Kidney Cancer or Renal Cancer Breakdown Data by Application
5.1 Global Kidney Cancer or Renal Cancer Historic Market Size by Application (2021–2026)
5.2 Global Kidney Cancer or Renal Cancer Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Kidney Cancer or Renal Cancer Market Size (2021–2032)
6.2 North America Kidney Cancer or Renal Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Kidney Cancer or Renal Cancer Market Size by Country (2021–2026)
6.4 North America Kidney Cancer or Renal Cancer Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Kidney Cancer or Renal Cancer Market Size (2021–2032)
7.2 Europe Kidney Cancer or Renal Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Kidney Cancer or Renal Cancer Market Size by Country (2021–2026)
7.4 Europe Kidney Cancer or Renal Cancer Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Kidney Cancer or Renal Cancer Market Size (2021–2032)
8.2 Asia-Pacific Kidney Cancer or Renal Cancer Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Kidney Cancer or Renal Cancer Market Size by Region (2021–2026)
8.4 Asia-Pacific Kidney Cancer or Renal Cancer Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Kidney Cancer or Renal Cancer Market Size (2021–2032)
9.2 Latin America Kidney Cancer or Renal Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Kidney Cancer or Renal Cancer Market Size by Country (2021–2026)
9.4 Latin America Kidney Cancer or Renal Cancer Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kidney Cancer or Renal Cancer Market Size (2021–2032)
10.2 Middle East & Africa Kidney Cancer or Renal Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Kidney Cancer or Renal Cancer Market Size by Country (2021–2026)
10.4 Middle East & Africa Kidney Cancer or Renal Cancer Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Kidney Cancer or Renal Cancer Introduction
11.1.4 Novartis Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Kidney Cancer or Renal Cancer Introduction
11.2.4 Gilead Sciences Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.2.5 Gilead Sciences Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Kidney Cancer or Renal Cancer Introduction
11.3.4 Roche Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.3.5 Roche Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Kidney Cancer or Renal Cancer Introduction
11.4.4 Bristol-Myers Squibb Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Kidney Cancer or Renal Cancer Introduction
11.5.4 Amgen Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.5.5 Amgen Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Kidney Cancer or Renal Cancer Introduction
11.6.4 AstraZeneca Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.6.5 AstraZeneca Recent Development
11.7 Merck & Co
11.7.1 Merck & Co Company Details
11.7.2 Merck & Co Business Overview
11.7.3 Merck & Co Kidney Cancer or Renal Cancer Introduction
11.7.4 Merck & Co Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.7.5 Merck & Co Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Kidney Cancer or Renal Cancer Introduction
11.8.4 Takeda Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.8.5 Takeda Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Kidney Cancer or Renal Cancer Introduction
11.9.4 Merck KGaA Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.9.5 Merck KGaA Recent Development
11.10 Seagen
11.10.1 Seagen Company Details
11.10.2 Seagen Business Overview
11.10.3 Seagen Kidney Cancer or Renal Cancer Introduction
11.10.4 Seagen Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.10.5 Seagen Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Kidney Cancer or Renal Cancer Introduction
11.11.4 Eli Lilly Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.11.5 Eli Lilly Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Kidney Cancer or Renal Cancer Introduction
11.12.4 Pfizer Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.12.5 Pfizer Recent Development
11.13 GSK
11.13.1 GSK Company Details
11.13.2 GSK Business Overview
11.13.3 GSK Kidney Cancer or Renal Cancer Introduction
11.13.4 GSK Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.13.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney Cancer or Renal Cancer Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.3 Market by Application
1.3.1 Global Kidney Cancer or Renal Cancer Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Kidney Cancer or Renal Cancer Market Perspective (2021–2032)
2.2 Global Kidney Cancer or Renal Cancer Growth Trends by Region
2.2.1 Global Kidney Cancer or Renal Cancer Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Kidney Cancer or Renal Cancer Historic Market Size by Region (2021–2026)
2.2.3 Kidney Cancer or Renal Cancer Forecasted Market Size by Region (2027–2032)
2.3 Kidney Cancer or Renal Cancer Market Dynamics
2.3.1 Kidney Cancer or Renal Cancer Industry Trends
2.3.2 Kidney Cancer or Renal Cancer Market Drivers
2.3.3 Kidney Cancer or Renal Cancer Market Challenges
2.3.4 Kidney Cancer or Renal Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kidney Cancer or Renal Cancer Players by Revenue
3.1.1 Global Top Kidney Cancer or Renal Cancer Players by Revenue (2021–2026)
3.1.2 Global Kidney Cancer or Renal Cancer Revenue Market Share by Players (2021–2026)
3.2 Global Top Kidney Cancer or Renal Cancer Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Kidney Cancer or Renal Cancer Revenue
3.4 Global Kidney Cancer or Renal Cancer Market Concentration Ratio
3.4.1 Global Kidney Cancer or Renal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer or Renal Cancer Revenue in 2025
3.5 Global Key Players of Kidney Cancer or Renal Cancer Head Offices and Areas Served
3.6 Global Key Players of Kidney Cancer or Renal Cancer, Products and Applications
3.7 Global Key Players of Kidney Cancer or Renal Cancer, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Kidney Cancer or Renal Cancer Breakdown Data by Type
4.1 Global Kidney Cancer or Renal Cancer Historic Market Size by Type (2021–2026)
4.2 Global Kidney Cancer or Renal Cancer Forecasted Market Size by Type (2027–2032)
5 Kidney Cancer or Renal Cancer Breakdown Data by Application
5.1 Global Kidney Cancer or Renal Cancer Historic Market Size by Application (2021–2026)
5.2 Global Kidney Cancer or Renal Cancer Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Kidney Cancer or Renal Cancer Market Size (2021–2032)
6.2 North America Kidney Cancer or Renal Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Kidney Cancer or Renal Cancer Market Size by Country (2021–2026)
6.4 North America Kidney Cancer or Renal Cancer Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Kidney Cancer or Renal Cancer Market Size (2021–2032)
7.2 Europe Kidney Cancer or Renal Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Kidney Cancer or Renal Cancer Market Size by Country (2021–2026)
7.4 Europe Kidney Cancer or Renal Cancer Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Kidney Cancer or Renal Cancer Market Size (2021–2032)
8.2 Asia-Pacific Kidney Cancer or Renal Cancer Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Kidney Cancer or Renal Cancer Market Size by Region (2021–2026)
8.4 Asia-Pacific Kidney Cancer or Renal Cancer Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Kidney Cancer or Renal Cancer Market Size (2021–2032)
9.2 Latin America Kidney Cancer or Renal Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Kidney Cancer or Renal Cancer Market Size by Country (2021–2026)
9.4 Latin America Kidney Cancer or Renal Cancer Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kidney Cancer or Renal Cancer Market Size (2021–2032)
10.2 Middle East & Africa Kidney Cancer or Renal Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Kidney Cancer or Renal Cancer Market Size by Country (2021–2026)
10.4 Middle East & Africa Kidney Cancer or Renal Cancer Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Kidney Cancer or Renal Cancer Introduction
11.1.4 Novartis Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Kidney Cancer or Renal Cancer Introduction
11.2.4 Gilead Sciences Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.2.5 Gilead Sciences Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Kidney Cancer or Renal Cancer Introduction
11.3.4 Roche Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.3.5 Roche Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Kidney Cancer or Renal Cancer Introduction
11.4.4 Bristol-Myers Squibb Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Kidney Cancer or Renal Cancer Introduction
11.5.4 Amgen Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.5.5 Amgen Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Kidney Cancer or Renal Cancer Introduction
11.6.4 AstraZeneca Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.6.5 AstraZeneca Recent Development
11.7 Merck & Co
11.7.1 Merck & Co Company Details
11.7.2 Merck & Co Business Overview
11.7.3 Merck & Co Kidney Cancer or Renal Cancer Introduction
11.7.4 Merck & Co Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.7.5 Merck & Co Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Kidney Cancer or Renal Cancer Introduction
11.8.4 Takeda Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.8.5 Takeda Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Kidney Cancer or Renal Cancer Introduction
11.9.4 Merck KGaA Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.9.5 Merck KGaA Recent Development
11.10 Seagen
11.10.1 Seagen Company Details
11.10.2 Seagen Business Overview
11.10.3 Seagen Kidney Cancer or Renal Cancer Introduction
11.10.4 Seagen Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.10.5 Seagen Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Kidney Cancer or Renal Cancer Introduction
11.11.4 Eli Lilly Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.11.5 Eli Lilly Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Kidney Cancer or Renal Cancer Introduction
11.12.4 Pfizer Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.12.5 Pfizer Recent Development
11.13 GSK
11.13.1 GSK Company Details
11.13.2 GSK Business Overview
11.13.3 GSK Kidney Cancer or Renal Cancer Introduction
11.13.4 GSK Revenue in Kidney Cancer or Renal Cancer Business (2021–2026)
11.13.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Kidney Cancer or Renal Cancer Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Immunotherapy
Table 5. Global Kidney Cancer or Renal Cancer Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Kidney Cancer or Renal Cancer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Kidney Cancer or Renal Cancer Market Size by Region (US$ Million), 2021–2026
Table 8. Global Kidney Cancer or Renal Cancer Market Share by Region (2021–2026)
Table 9. Global Kidney Cancer or Renal Cancer Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Kidney Cancer or Renal Cancer Market Share by Region (2027–2032)
Table 11. Kidney Cancer or Renal Cancer Market Trends
Table 12. Kidney Cancer or Renal Cancer Market Drivers
Table 13. Kidney Cancer or Renal Cancer Market Challenges
Table 14. Kidney Cancer or Renal Cancer Market Restraints
Table 15. Global Kidney Cancer or Renal Cancer Revenue by Players (US$ Million), 2021–2026
Table 16. Global Kidney Cancer or Renal Cancer Market Share by Players (2021–2026)
Table 17. Global Top Kidney Cancer or Renal Cancer Players by Tier (Tier 1, Tier 2, and Tier 3), based on Kidney Cancer or Renal Cancer Revenue, 2025
Table 18. Ranking of Global Top Kidney Cancer or Renal Cancer Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Kidney Cancer or Renal Cancer Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Kidney Cancer or Renal Cancer, Headquarters and Area Served
Table 21. Global Key Players of Kidney Cancer or Renal Cancer, Products and Applications
Table 22. Global Key Players of Kidney Cancer or Renal Cancer, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Kidney Cancer or Renal Cancer Market Size by Type (US$ Million), 2021–2026
Table 25. Global Kidney Cancer or Renal Cancer Revenue Market Share by Type (2021–2026)
Table 26. Global Kidney Cancer or Renal Cancer Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Kidney Cancer or Renal Cancer Revenue Market Share by Type (2027–2032)
Table 28. Global Kidney Cancer or Renal Cancer Market Size by Application (US$ Million), 2021–2026
Table 29. Global Kidney Cancer or Renal Cancer Revenue Market Share by Application (2021–2026)
Table 30. Global Kidney Cancer or Renal Cancer Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Kidney Cancer or Renal Cancer Revenue Market Share by Application (2027–2032)
Table 32. North America Kidney Cancer or Renal Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2021–2026
Table 34. North America Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Kidney Cancer or Renal Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Kidney Cancer or Renal Cancer Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Kidney Cancer or Renal Cancer Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Kidney Cancer or Renal Cancer Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Kidney Cancer or Renal Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Kidney Cancer or Renal Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2027–2032
Table 47. Novartis Company Details
Table 48. Novartis Business Overview
Table 49. Novartis Kidney Cancer or Renal Cancer Product
Table 50. Novartis Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 51. Novartis Recent Development
Table 52. Gilead Sciences Company Details
Table 53. Gilead Sciences Business Overview
Table 54. Gilead Sciences Kidney Cancer or Renal Cancer Product
Table 55. Gilead Sciences Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 56. Gilead Sciences Recent Development
Table 57. Roche Company Details
Table 58. Roche Business Overview
Table 59. Roche Kidney Cancer or Renal Cancer Product
Table 60. Roche Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 61. Roche Recent Development
Table 62. Bristol-Myers Squibb Company Details
Table 63. Bristol-Myers Squibb Business Overview
Table 64. Bristol-Myers Squibb Kidney Cancer or Renal Cancer Product
Table 65. Bristol-Myers Squibb Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 66. Bristol-Myers Squibb Recent Development
Table 67. Amgen Company Details
Table 68. Amgen Business Overview
Table 69. Amgen Kidney Cancer or Renal Cancer Product
Table 70. Amgen Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 71. Amgen Recent Development
Table 72. AstraZeneca Company Details
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Kidney Cancer or Renal Cancer Product
Table 75. AstraZeneca Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 76. AstraZeneca Recent Development
Table 77. Merck & Co Company Details
Table 78. Merck & Co Business Overview
Table 79. Merck & Co Kidney Cancer or Renal Cancer Product
Table 80. Merck & Co Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 81. Merck & Co Recent Development
Table 82. Takeda Company Details
Table 83. Takeda Business Overview
Table 84. Takeda Kidney Cancer or Renal Cancer Product
Table 85. Takeda Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 86. Takeda Recent Development
Table 87. Merck KGaA Company Details
Table 88. Merck KGaA Business Overview
Table 89. Merck KGaA Kidney Cancer or Renal Cancer Product
Table 90. Merck KGaA Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 91. Merck KGaA Recent Development
Table 92. Seagen Company Details
Table 93. Seagen Business Overview
Table 94. Seagen Kidney Cancer or Renal Cancer Product
Table 95. Seagen Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 96. Seagen Recent Development
Table 97. Eli Lilly Company Details
Table 98. Eli Lilly Business Overview
Table 99. Eli Lilly Kidney Cancer or Renal Cancer Product
Table 100. Eli Lilly Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 101. Eli Lilly Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Kidney Cancer or Renal Cancer Product
Table 105. Pfizer Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 106. Pfizer Recent Development
Table 107. GSK Company Details
Table 108. GSK Business Overview
Table 109. GSK Kidney Cancer or Renal Cancer Product
Table 110. GSK Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 111. GSK Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Kidney Cancer or Renal Cancer Picture
Figure 2. Global Kidney Cancer or Renal Cancer Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Kidney Cancer or Renal Cancer Market Share by Type: 2025 vs 2032
Figure 4. Targeted Therapy Features
Figure 5. Chemotherapy Features
Figure 6. Immunotherapy Features
Figure 7. Global Kidney Cancer or Renal Cancer Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Kidney Cancer or Renal Cancer Market Share by Application: 2025 vs 2032
Figure 9. Hospital Case Studies
Figure 10. Pharmacy Case Studies
Figure 11. Other Case Studies
Figure 12. Kidney Cancer or Renal Cancer Report Years Considered
Figure 13. Global Kidney Cancer or Renal Cancer Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Kidney Cancer or Renal Cancer Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Kidney Cancer or Renal Cancer Market Share by Region: 2025 vs 2032
Figure 16. Global Kidney Cancer or Renal Cancer Market Share by Players in 2025
Figure 17. Global Kidney Cancer or Renal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Kidney Cancer or Renal Cancer Revenue in 2025
Figure 19. North America Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Kidney Cancer or Renal Cancer Market Share by Country (2021–2032)
Figure 21. United States Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Kidney Cancer or Renal Cancer Market Share by Country (2021–2032)
Figure 25. Germany Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Kidney Cancer or Renal Cancer Market Share by Region (2021–2032)
Figure 33. China Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Kidney Cancer or Renal Cancer Market Share by Country (2021–2032)
Figure 41. Mexico Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Kidney Cancer or Renal Cancer Market Share by Country (2021–2032)
Figure 45. Israel Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Novartis Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 49. Gilead Sciences Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 50. Roche Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 52. Amgen Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 53. AstraZeneca Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 54. Merck & Co Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 55. Takeda Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 56. Merck KGaA Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 57. Seagen Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 58. Eli Lilly Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 59. Pfizer Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 60. GSK Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Kidney Cancer or Renal Cancer Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Immunotherapy
Table 5. Global Kidney Cancer or Renal Cancer Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Kidney Cancer or Renal Cancer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Kidney Cancer or Renal Cancer Market Size by Region (US$ Million), 2021–2026
Table 8. Global Kidney Cancer or Renal Cancer Market Share by Region (2021–2026)
Table 9. Global Kidney Cancer or Renal Cancer Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Kidney Cancer or Renal Cancer Market Share by Region (2027–2032)
Table 11. Kidney Cancer or Renal Cancer Market Trends
Table 12. Kidney Cancer or Renal Cancer Market Drivers
Table 13. Kidney Cancer or Renal Cancer Market Challenges
Table 14. Kidney Cancer or Renal Cancer Market Restraints
Table 15. Global Kidney Cancer or Renal Cancer Revenue by Players (US$ Million), 2021–2026
Table 16. Global Kidney Cancer or Renal Cancer Market Share by Players (2021–2026)
Table 17. Global Top Kidney Cancer or Renal Cancer Players by Tier (Tier 1, Tier 2, and Tier 3), based on Kidney Cancer or Renal Cancer Revenue, 2025
Table 18. Ranking of Global Top Kidney Cancer or Renal Cancer Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Kidney Cancer or Renal Cancer Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Kidney Cancer or Renal Cancer, Headquarters and Area Served
Table 21. Global Key Players of Kidney Cancer or Renal Cancer, Products and Applications
Table 22. Global Key Players of Kidney Cancer or Renal Cancer, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Kidney Cancer or Renal Cancer Market Size by Type (US$ Million), 2021–2026
Table 25. Global Kidney Cancer or Renal Cancer Revenue Market Share by Type (2021–2026)
Table 26. Global Kidney Cancer or Renal Cancer Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Kidney Cancer or Renal Cancer Revenue Market Share by Type (2027–2032)
Table 28. Global Kidney Cancer or Renal Cancer Market Size by Application (US$ Million), 2021–2026
Table 29. Global Kidney Cancer or Renal Cancer Revenue Market Share by Application (2021–2026)
Table 30. Global Kidney Cancer or Renal Cancer Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Kidney Cancer or Renal Cancer Revenue Market Share by Application (2027–2032)
Table 32. North America Kidney Cancer or Renal Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2021–2026
Table 34. North America Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Kidney Cancer or Renal Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Kidney Cancer or Renal Cancer Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Kidney Cancer or Renal Cancer Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Kidney Cancer or Renal Cancer Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Kidney Cancer or Renal Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Kidney Cancer or Renal Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Kidney Cancer or Renal Cancer Market Size by Country (US$ Million), 2027–2032
Table 47. Novartis Company Details
Table 48. Novartis Business Overview
Table 49. Novartis Kidney Cancer or Renal Cancer Product
Table 50. Novartis Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 51. Novartis Recent Development
Table 52. Gilead Sciences Company Details
Table 53. Gilead Sciences Business Overview
Table 54. Gilead Sciences Kidney Cancer or Renal Cancer Product
Table 55. Gilead Sciences Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 56. Gilead Sciences Recent Development
Table 57. Roche Company Details
Table 58. Roche Business Overview
Table 59. Roche Kidney Cancer or Renal Cancer Product
Table 60. Roche Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 61. Roche Recent Development
Table 62. Bristol-Myers Squibb Company Details
Table 63. Bristol-Myers Squibb Business Overview
Table 64. Bristol-Myers Squibb Kidney Cancer or Renal Cancer Product
Table 65. Bristol-Myers Squibb Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 66. Bristol-Myers Squibb Recent Development
Table 67. Amgen Company Details
Table 68. Amgen Business Overview
Table 69. Amgen Kidney Cancer or Renal Cancer Product
Table 70. Amgen Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 71. Amgen Recent Development
Table 72. AstraZeneca Company Details
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Kidney Cancer or Renal Cancer Product
Table 75. AstraZeneca Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 76. AstraZeneca Recent Development
Table 77. Merck & Co Company Details
Table 78. Merck & Co Business Overview
Table 79. Merck & Co Kidney Cancer or Renal Cancer Product
Table 80. Merck & Co Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 81. Merck & Co Recent Development
Table 82. Takeda Company Details
Table 83. Takeda Business Overview
Table 84. Takeda Kidney Cancer or Renal Cancer Product
Table 85. Takeda Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 86. Takeda Recent Development
Table 87. Merck KGaA Company Details
Table 88. Merck KGaA Business Overview
Table 89. Merck KGaA Kidney Cancer or Renal Cancer Product
Table 90. Merck KGaA Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 91. Merck KGaA Recent Development
Table 92. Seagen Company Details
Table 93. Seagen Business Overview
Table 94. Seagen Kidney Cancer or Renal Cancer Product
Table 95. Seagen Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 96. Seagen Recent Development
Table 97. Eli Lilly Company Details
Table 98. Eli Lilly Business Overview
Table 99. Eli Lilly Kidney Cancer or Renal Cancer Product
Table 100. Eli Lilly Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 101. Eli Lilly Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Kidney Cancer or Renal Cancer Product
Table 105. Pfizer Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 106. Pfizer Recent Development
Table 107. GSK Company Details
Table 108. GSK Business Overview
Table 109. GSK Kidney Cancer or Renal Cancer Product
Table 110. GSK Revenue in Kidney Cancer or Renal Cancer Business (US$ Million), 2021–2026
Table 111. GSK Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Kidney Cancer or Renal Cancer Picture
Figure 2. Global Kidney Cancer or Renal Cancer Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Kidney Cancer or Renal Cancer Market Share by Type: 2025 vs 2032
Figure 4. Targeted Therapy Features
Figure 5. Chemotherapy Features
Figure 6. Immunotherapy Features
Figure 7. Global Kidney Cancer or Renal Cancer Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Kidney Cancer or Renal Cancer Market Share by Application: 2025 vs 2032
Figure 9. Hospital Case Studies
Figure 10. Pharmacy Case Studies
Figure 11. Other Case Studies
Figure 12. Kidney Cancer or Renal Cancer Report Years Considered
Figure 13. Global Kidney Cancer or Renal Cancer Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Kidney Cancer or Renal Cancer Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Kidney Cancer or Renal Cancer Market Share by Region: 2025 vs 2032
Figure 16. Global Kidney Cancer or Renal Cancer Market Share by Players in 2025
Figure 17. Global Kidney Cancer or Renal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Kidney Cancer or Renal Cancer Revenue in 2025
Figure 19. North America Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Kidney Cancer or Renal Cancer Market Share by Country (2021–2032)
Figure 21. United States Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Kidney Cancer or Renal Cancer Market Share by Country (2021–2032)
Figure 25. Germany Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Kidney Cancer or Renal Cancer Market Share by Region (2021–2032)
Figure 33. China Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Kidney Cancer or Renal Cancer Market Share by Country (2021–2032)
Figure 41. Mexico Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Kidney Cancer or Renal Cancer Market Share by Country (2021–2032)
Figure 45. Israel Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Kidney Cancer or Renal Cancer Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Novartis Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 49. Gilead Sciences Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 50. Roche Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 52. Amgen Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 53. AstraZeneca Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 54. Merck & Co Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 55. Takeda Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 56. Merck KGaA Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 57. Seagen Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 58. Eli Lilly Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 59. Pfizer Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 60. GSK Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232